electroCore to Present at the Canaccord Genuity Growth Conference
02 Agosto 2021 - 9:00AM
electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a
commercial-stage bioelectronic medicine company, today announced
that its management team will give a corporate presentation and be
available for virtual one-on-one meetings at the Canaccord Genuity
Growth Conference. The conference is taking place virtually from
August 10 - 12, 2021. Details for the presentation are as follows:
Canaccord Genuity Growth Conference:Date:
Thursday, August 12, 2021Time: 8:30 am EDTInvestors can register
for the conference HERE.Following the conference a webcast replay
of the presentation will be available on the Investor section of
the company’s website, www.electrocore.com.
About electroCore, Inc.electroCore, Inc. is a
commercial stage bioelectronic medicine company dedicated to
improving patient outcomes through its non-invasive vagus nerve
stimulation therapy platform, initially focused on the treatment of
multiple conditions in neurology. The company's current indications
are the preventive treatment of cluster headache and migraine and
the acute treatment of migraine and episodic cluster headache.
For more information, visit www.electrocore.com.
Investors:
Rich Cockrell
CG Capital
404-736-3838
ecor@cg.capital
or
Media Contact:
Jackie Dorsky
electroCore
908-313-6331
Jackie.dorsky@electrocore.com
electroCore (NASDAQ:ECOR)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
electroCore (NASDAQ:ECOR)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024